a b s t r a c t HIV CRF07 B′/C is a strain circulating mainly in northwest region of China. The gp41 region of CRF07 is derived from a clade C virus. In order to compare the difference of CRF07 gp41 with that of typical clade B virus, we solved the crystal structure of the core region of CRF07 gp41. Compared with clade B gp41, CRF07 gp41 evolved more basic and hydrophilic residues on its helix bundle surface. Based on sequence alignment, a hyper-mutant cluster located in the middle of HR2 heptads repeat was identified. The mutational study of these residues revealed that this site is important in HIV mediated cell-cell fusion and plays critical roles in conformational changes during viral invasion.
Introduction
The viral replication, virus-host interaction, and therapeutic intervention of human immunodeficiency virus (HIV), the etiological agent of acquired immune deficiency syndrome (AIDS) have been extensively studied (Gorry and Ancuta, 2011; Murakami and Yamamoto, 2000; Vandegraaff and Engelman, 2007) . There has been huge progress in the discovery of dozens of inhibitors to control every step of the life-cycle of HIV (Currier and Havlir, 2009; Havlir and Currier, 2006; Luetkemeyer et al., 2012) . Despite these advances, however, there is still no way to completely eliminate the virus from the human body (Garber et al., 2004) . Even with the help of a cocktail of inhibitors, most infected individuals will eventually lose control over the virus and succumb to secondary infections (Kadow et al., 2006; Tamamura and Fujii, 2004) . Though clade B HIV was the dominant strain when HIV was first isolated (Bagetta et al., 1999; Barnett et al., 1997; Riabinina et al., 2007) , global spreading of the virus has led to the identification of many other clades and circulating recombination forms (CRF), some of which emerged during spread by gene mutation and recombination (Butler et al., 2007; Peeters and Delaporte, 1999) .
HIV relies on gp120 and gp41 to attach to the host cell membrane (Chazal and Gerlier, 2003; Clapham and McKnight, 2002; Hu et al., 2012; Wilen et al., 2012; Wyatt et al., 1998) . Through the sequential binding of gp120 to the CD4 receptor and CCR5/CXCR4 co-receptor (Davis et al., 1997) , the fusion peptides buried within the gp120/gp41 trimer are exposed and mediate membrane fusion between the virion and the host cell (Edinger and Doms, 1999; Markosyan et al., 2002; Roy et al., 2013; Yee et al., 2011) . Though gp41 is not well-exposed on viral surface, making it difficult to be targeted by neutralizing antibodies, its high sequence conservation and, to a lesser extent, glycosylation pattern make it a good target for broad spectrum neutralizing antibody induction and vaccine development. Several antibodies against gp41 in HIV, such as 2F5, 4E10, and 10E8, have already been identified and shown to neutralize a wide spectrum of HIV isolates (Huarte et al., 2011; Pejchal and Wilson, 2010; Phogat and Wyatt, 2007; Weiss, 2003) . Crystal structures of HIV gp41 are therefore critical in understanding the molecular interactions in these neutralization events. All reported gp41 structures, even those with varying helical region lengths, are shown to contain a stable six-helix bundle, with three N-terminal heptad repeats (HR1) forming the core of the coiled-coil and the other three C-terminal heptad repeats (HR2) lining the outside in an anti-parallel fashion (Chan et al., 1997; Liu et al., 2009; O'Rourke et al., 2009) . Recently, a crystal structure of HIV gp41 containing the FPPR (fusion peptide proximal region) and MPER (membrane proximal external region) was also reported (PDB code 2 Â 7R) (Buzon et al., 2010) .
Due to the lack of proofreading ability of the HIV reverse transcriptase, many mutations are accumulated and selected for by the host immune system during virus infection. Gene recombination also occurs frequently during virus replication (An and Telesnitsky, 2002; Burke, 1997; Chen et al., 2012; Motomura et al., 2008; Saksena et al., 1997; Yabar et al., 2012) . These factors contribute to the diversity of circulating virus in a community or even within a single host. The selection of a specific sequence of HIV is a consequence of both the necessity of viral viability and pressure from the host immune system. The envelope protein, including the gp120 and gp41 subunits, is the most divergent protein in HIV. Its adaptation to the unique and changing environment is crucial for the survival of the virus (Burke, 1997) . The adaption of gp120 and gp41 through changes in both primary sequence and spatial conformation is not only pivotal for escaping antibody neutralizing against the virus, but is also critical for the maintenance of viral infection and replication (Archer et al., 2008) .
HIV CRF07 B′/C is a recombined form of virus circulating mainly in northwest China where the gp41 subunit is derived from a clade C virus Meng et al., 2012; Shao et al., 2012; Song et al., 2012) . Compared to typical clade B viruses, most of differing residues in the gp41 core region are located within the HR2 heptad repeat (Matthews et al., 2000; Trivedi et al., 2003; Zhao et al., 2000) . Using the crystal structure reported here, we were able to localize most of the modified residues on the surface of the six-helix bundle. A hyper-mutated site located in the middle of HR2 was identified via sequence alignment. Individual point mutations of these residues suggest that this site is important for viral infection and adaptation. The hyper-mutated region affects the stability of viral spikes and interferes with conformational changes during viral infection. These mutations are complemented with other mutations within gp41 to maintain the full function of envelope proteins for efficient adaptation during infection. In this study, the relative conservation of these residues during evolution is also investigated and the possible conformational changes associated with these residues on gp41 during viral infection are discussed.
Results
The overall structure of CRF07 gp41
Based on the core structure of clade B, the CRF07 gp41 core region was subcloned and expressed in Escherichia coli (Chan et al., 1997) . The solubility of CRF07 gp41 is relatively acceptable in Tris-NaCl buffer and no organic solvent or harsh pH was required during protein purification. A high resolution dataset was collected on the protein crystal and the structure determined by molecular replacement using a searching model of clade B (PDB code 1AIK) (Chan et al., 1997; McCoy, 2007) . Results of data processing and structure determination are summarized in Table 1 . Unsurprisingly, the overall structure of CRF07 gp41 is very similar to clade B gp41, with an r.m.s.d. of Cα of about 1.15 Å. Four additional residues, derived from the cloning vector (QSND-), preceded gp41 and formed a continuous helix with HR1 (Fig. 1A) . The linker peptide (GGGGR) between HR1 and HR2 is visible clearly from the electron density map. Three water molecules were identified along the central axis, which formed H-bonds to polar residues from HR1 (Q552, Q562 and T569), contributing to the stabilization of the six-helix bundle. Superimposing to other gp41 structures of varying lengths shows that the relative orientation and distance within this six-helix bundle is quite similar, indicating a stable post-fusion conformation constituted by the core region, despite minor local conformational changes resulting from different gp41 constructs (Fig. 1B) . Compared to typical clade B gp41, the positions of the buried residues are barely changed despite more than a dozen residue mutations exist, mainly in HR2. These mutated residues influence the solvent accessibility and surface charge of the six-helix bundle. Overall, the surface of CRF07 is more basic and hydrophilic due to these mutations (Fig. 1C) .
The mutational sites of CRF07 compared with typical clade B From the sequence alignment of the CRF07 gp41 core region with that of clade B, 15 differing residues were identified in total, most of which are located within the HR2 heptad repeats ( Fig. 2A) , consistent with a previous observation that HR2 is more prone to mutations due to selection pressure of the host immune system (Aquaro et al., 2006; Ray et al., 2009) . To maintain the viability of the virus, gp41 subunits harboring these mutations must retain membrane fusion capability during viral infection. In order to investigate the effect of these mutations from an evolutionary point of view, the differing residues on CRF07 gp41 were individually mutated to the corresponding residues in clade B. The influence on cell-cell fusion of these mutations in the context of CRF07 were detected and summarized in Table 2 .
From our results, it is unsurprising that most of the mutations lead to the decrease, or even abolishment of fusion ability. The CRF07 strain has been circulating actively in Asia for more than a decade, and many of its unique residues are a consequence of natural selection of the virus and adaptation to the host environment. The mutations on these residues will reasonably incur fitness losses for the virus and the reduction in fusion ability is probably one of these consequences. Three mutations, T578A, K633R, and L646I, abolished the fusion ability completely (Table 2) , indicating these sites are critical in virus survival. Interestingly, two mutations, both mutations from Ser to Asn (S553N and S636N), increase the fusion ability significantly ( Table 2 ). The side chains of both mutations, one from HR1 and the other from HR2, were projected outwards on the six-helix bundle of gp41 based on crystal structure, implying the surface residues are also critical for proper function of gp41. From the crystal structure reported here, most of the mutated residues are located on the surface of the six-helix bundle. Their side chains, except V642I and L646I, protrude outwards and the corresponding mutations are not predicted to impact the stability of the helix bundle. To verify this hypothesis, the mutant proteins were purified and the stability measured by circular dichroism. Unsurprisingly, there were only minor changes to the melting temperature (Tm) of these mutants compared to wild-type CRF07 protein, indicating the alteration of fusion ability here is not due to changes in stability of the helix bundle (Table 2) , although a correlation has been observed in several other mutants. In summary, changes in the fusion ability due to mutations in CRF07 gp41 compared to clade B are the consequences of local conformational changes rather than the perturbing of post-fusion stability of gp41.
By checking the spatial position of mutations which significantly influence fusion and infection, i.e., the three negative mutants T578A, K633R, L646I and two positive mutants S533N and S636N, we observed that K633R localized closely to S636N on the N-terminal half of HR2 (Fig. 2B) . The disulfide bond loop region precedes the N-terminal half of HR2 and is, together with the N-terminus of HR2, presumably involved in the loop-to-helix transition during conformational change necessary for proper membrane fusion, a phenomenon observed in several membrane fusion proteins including gp41. Based on the crystal structure, T578A is also spatially close to this region (Fig. 2B) . The break of helix and a hairpin structure in HR1, where the N-and C-terminal halves are aligned in an anti-parallel fashion, has been suggested in pre-fusion state by Sanders et al. (2002) based on study of I559 mutations. If we take this pre-fusion hairpin structure into consideration, S553N may also be spatially close to this mutation hotspot prior to membrane fusion (Fig. 2B) .
The hyper-mutant cluster in the middle of HR2
The V642I and L646I are the only two mutations identified to protrude inward and are likely to interfere with the interaction of HR1 and HR2 within the six-helix bundle. Valine, isoleucine and leucine are all hydrophobic residues, so these mutations should be of little significance to the stability of the helix bundle. This speculation was supported by circular dichroism measurements of these mutants, which have similar Tm values to that of the wildtype protein (Table 2) . Surprisingly, despite the retention of wildtype fusion ability by the V642I mutant, there is nearly complete abolishment of cell-cell fusion with the L646I mutation. Based on crystal structure, L646 is adjacent to I559 in HR1, a critical position for gp120-gp41 conformation identified previously by Sanders et al. (2002) . Accompanying these two mutations, in the middle of the HR2 helix, a local hyper-mutant cluster of seven consecutive residues could be identified based on sequence alignment of CRF07 and clade B (Fig. 2A) . This hyper-mutant stretch was even more apparent when sequences of different virus clades were included (Fig. 3A) , implying that this region is another mutational hotspot for virus adaptation during spreading. In the crystal structure, this region is located within the N-terminal half of HR2, close to the helix center. All the structures reported for gp41 up to date are in a post-fusion conformation and no structural information is available in pre-or intermediate state (Buzon et al., 2010; Chan et al., 1997; Malashkevich et al., 1998; Weissenhorn et al., 1997) . Hypothetically, the gp41 is occluded mostly by gp120 within the spike of virus before infection occurs, with its fusion peptide buried inside (Hu et al., 2011; Mao et al., 2012 Mao et al., , 2013 Tran et al., 2012; Zhu et al., 2008) . At this stage, the long helices of HR1 and HR2 observed in crystal structure would only be partially formed. Based on our cell fusion assay, mutations within this cluster, in most cases, significantly altered the fusion ability of gp41. From the study above (Results section), we hypothesize the N-terminal half of HR2 would adopt a partially unstructured conformation which would exist within the spikes of infectious virus prior to fusion. To further explore the conformational change of this region during fusion, we performed a series of single proline mutations of this region. The introduction of proline, which would break the continuity of helix, was used by Sanders et al. (2002) to investigate the conformation of gp140. In their study, a stable gp140 was generated by a mutation (I559P) within HR1, suggesting a pre-fusion hairpin structure for HR1. In these mutations within the hyper-mutation cluster, an obvious loss of function similar to that of the I559P mutant was observed in the cell fusion assay (Table 3) . One exception, N640P, retains fusion ability similar to the wild-type, suggesting that the breakdown of the helix within the N-terminal half of HR2 is not always fatal for protein function. Measurement of the melting temperature with circular dichroism showed that the Tm of all mutants decreased significantly (Table 3 ). The location of this mutation again attracts our attention to the N-terminal half of HR2, where several critical mutations, such as K633R, S636N, have been identified (Fig. 3B) . The tolerance of a proline mutation within this region suggests a flexible conformation is necessary for proper function of gp41, and the rigidity of a continuous helix is not always critical for viral infection. 
The gp41 activity detected by pseudo-virus infection
To verify the membrane fusion activity of gp41 mutants at the viral infection level, a pseudo-virus infection system using onecycle entry was used to determine the influence of these mutations on infection (Montefiori, 2005; Thayil et al., 2012; Yao et al., 2012) . Three critical mutations identified above, S553N, S636N and N640P, were tested. For S553N and S636N, both of which acquired significant increases in membrane fusion activity based on the cell fusion assay, also showed significant increases in viral infection ability (Fig. 4A) , a phenomenon that cannot be attributed to mere variations in protein expression. For N640P, it is also obvious the mutation has only a mild effect on viral infection compared with the wild-type (Fig. 4B) . Taken together, our observation of gp41 activity based on cell fusion is reliable and further confirmed by our results in the pseudo-virus infection system.
Discussion
The crystal structure of gp41 is well-characterized. Following the determination of the structure of the N36-C34 peptides comprising the core region (Chan et al., 1997) , different lengths of HR1 and HR2 were constituted intended to reveal the conformation along this core region. Recently, the crystal structure of complete extracellular domain of gp41 lacking the fusion peptide and cysteine-linked loop (pdb code 2 Â 7R) was determined (Buzon et al., 2010) . In this crystal, where formation was facilitated by a high concentration of MPD, both the fusion peptide proximal region (FPPR) and membrane proximal external region (MPER) form α-helices along the core region of gp41, indicating a dominant potency to form helices in the residues neighboring the heptad repeats. Unfortunately, all structures reported to date characterized by a six-helix bundle conformation are of the postfusion state of gp41. The pre-fusion structure of gp41, which is stabilized by interaction with gp120, is unlikely to be obtained easily due to the unstable high-energy state. For the purpose of vaccine development, the detailed conformation of the pre-fusion state, found in the native spikes of virus, must be urgently established. This could be explored by investigating the mutations generated naturally during virus spreading. The virus must retain the conserved residues for survival; non-essential residues can be mutated for adaptation purposes. Based on this hypothesis, we compared the sequence of CRF07 and clade B virus and systematically mutated the non-conserved residues to determine their influence on viral infection. The crystal structure of CRF07 core region reported here is similar to gp41 structures from other clades. By analyzing the consequence of mutations on viral infection, we could identify a hotspot located within N-terminal half of HR2. This region is hyper-mutated between different clades which, despite natural variation among various clades, could lead to striking consequences (abolishment or increase) on viral infection. The introduction of proline within this region to disrupt helix continuity revealed a site where modulation is tolerable, Table 3 Cell fusion of mutants in hyper-mutated cluster. The vector pcDNA3.1 and wild type are negative and positive control, respectively. The results shown are the average of three independent experiments. And the Tm was calculated with a Boltzmann sigmoidal fit using OriginLab. N/A, no available mutation identified.
Number Mutation site
Cell-fusion activity indicating that a flexibility within this region is indispensable for effective replication of virus. Recently, with higher resolution of HIV-1 Env trimer from single particle cryo-electron microscopy (cryo-EM) (Mao et al., 2012 (Mao et al., , 2013 Tran et al., 2012) , more details for conformation of pre-fusion gp41 is characterized. The HR1 helix is formed first in an activated intermediate induced by antibody 17b binding (Tran et al., 2012) preceding the full pre-hairpin intermediate formation.
While in an unliganded Env trimer without C-terminal intracellular region (Env( À )ΔCT), 7-8 short α-helices for each gp41 ectodomain are discovered, which is significantly different from the six-helix bundle post-fusion architecture (Mao et al., 2013) . All these information, together with mutational study reported here, lead to a conclusion of striking conformational change comprising transition from loop to helix is required for functional gp41 in membrane fusion process.
The local loop-to-helix transition has been observed in various membrane fusion proteins, such as HA2, in which the availability of both pre-and post-fusion structure allow us to depict this kind of transition in atomic detail (Bosch et al., 1981; Huang et al., 2009; Lu et al., 2012) . The MPER region of gp41 could exist in either α-helix or an extended loop, depending on the context of the surroundings or antibody binding, supporting the different structures observed during various stage of viral infection (Coutant et al., 2008; Harris et al., 2013; Hartono et al., 2013; Hinz et al., 2009; Peachman et al., 2010) . The length of helix in the extracellular region of the crystal structure extended nearly 80 Å in HIV gp41 (pdb code 2 Â 7R) and the length of the helix in SIV gp41 (pdb code 1QBZ) is even longer (Caffrey et al., 1998; Malashkevich et al., 1998; Yang et al., 1999) . As a comparison, the breadth of gp120 without V1V2 and V3 loops is less than 50 Å in either dimension (Guttman et al., 2012; Huang et al., 2005; Joyce et al., 2013; Kwong et al., 1998; Pancera et al., 2010; Wyatt et al., 1998) . It is reasonable to speculate that the helices of gp41 are not fully assembled in the pre-fusion state within the viral spikes. The results with the I559P mutant described a possible hairpin structure for HR1 (Sanders et al., 2002) , and mutations within the N-terminal half of HR2 in our study support the hypothesis that a flexible or even unstructured loop conformation could exist within HR2. Based on these observations and recent high resolution cryo-EM data (Mao et al., 2012 (Mao et al., , 2013 Tran et al., 2012) , we could propose a pre-fusion model for gp41 in which both HR1 and HR2 are broken in the middle (or more sites) and a coordinated loop-to-helix transition is necessary for viral fusion (Fig. 5) . HIV gp41 could go through the following steps to drive membrane fusion. (a) The gp41 protein in the native conformation, with the fusion peptide sequestered. In the native state, HR1 and HR2 are broken in the middle or more sites and a coordinated loop-tohelix transition is necessary for viral fusion. (b) Transition stage of the virus-cell membrane fusion. HIV-1 gp41 HR1 and HR2 broken loop transform to helix and expose the N-terminal fusion peptide. It seems HR1 assembled first prior to HR2 assembly (Tran et al., 2012) . (c) Extended intermediate stage of the fusion. After the loop-to-helix transition of HIV gp41, the protein opens up, extending the fusion peptide to interact with the target membrane bilayer. (d) The post-fusion stage: the C-terminal segment of gp41 folds back along the outside of the trimer core. The membrane collapse and bring the two bilayers into contact, then the bilayers form a fusion pore. Finally, zipping up of the ectodomain segment snaps the refolded trimer into fully symmetric, post fusion conformation.
The tolerance of the N640P mutation in viral infection is surprising, considering the importance of a stable helix within HR2 heptad repeat region. In all atomic structures of HIV gp41 reported to date, a helix conformation around the N640 region has always been present. The viability of virus bearing this mutation indicates a functional envelope spike with proper conformation during the pre-fusion stage. In contrast to the complete loss of function in the I559P mutant, the viability of N640P implies that this mutation is completely tolerable for viral infection. An envelope spike must undergo a conformational transition from pre-to intermediate-to post-fusion stages. Our data strongly suggests that conformational flexibility, even a turn substituted for a continuous helix around N640, is acceptable. A dramatic conformational transition, probably from turn/loop to helix, is postulated at N640, which acts in concert with other conformational changes in neighboring residues within the hyper-mutation site (Fig. 4) . Due to the lack of structural information about the pre-fusion state of envelope proteins, immunogen design in vaccine development efforts based on envelope proteins is tremendously impeded. Our study on the conformational transition of gp41 should provide useful insights into the mechanism of HIV infection and vaccine research.
Materials and methods

Plasmids and molecular cloning
The ectodomain of CRF07 gp41 was constructed based on the B subtype HIV gp41 reported previously (Chan et al., 1997) . HR1 and HR2 were connected by a GGGGR linker, HR1-GGGGR-HR2 (GGGGR). Fragments of CRF07 gp41 were amplified by overlapping PCR and cloned into the pET30-TEV/LIC expression vector (Novagen, Germany) with a 6 Â His-tag for purification, called pET30-gp41. The HIV ENV protein used in cell-cell fusion was expressed in eukaryotic expression vector pSRH NLA/S/Av (kindly provided by Dr. Eric Hunter, Emory University, GA, USA), pSRHS-gp160. The QuikChange site-directed mutagenesis kit was used to generate point mutation and amino acid exchanges. The procedure was performed according to manufacturer's instructions.
Cells culture and transfection
293T, TZM-bl cells and COS-1 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS (fetal bovine serum), penicillin (50 U/ml) and streptomycin (50 mg/ml). Cells were maintained in a humidified atmosphere containing 5% CO 2 at 37 1C. The 293T and COS-1 cells were transfected by lipofectamine2000 (Invitrogen, USA) according to the manufacturer's instructions. 
Protein expression and purification
Gp41 was expressed in E. coli strain Rosetta (DE3) in Luria broth (LB) medium (50 μg/ml kanamycin). The culture was induced with 400 μM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 8 h at 20 1C for protein expression. Cells were harvested by centrifugation (6000g, 10 min, 20 1C) and resuspended in buffer A (50 mM Tris pH 8.0, 500 mM NaCl). Cells were lysed by sonication and the crude cell extract clarified by centrifugation (38,000g, 4 1C, 40 min) .
The supernatant was applied to Ni-NTA resin equilibrated in buffer A (50 mM Tris pH 8.0, 500 mM NaCl). The column was washed with 5 column volumes (CV) of buffer A containing 40 mM imidazole. Proteins bound to the column were eluted with buffer A containing 500 mM imidazole. The protein was further purified using a HiTrap Q HP column (GE Healthcare) with a linear gradient of NaCl from 100-1000 mM. Peak fractions eluted from the column were purified using a Superdex-200 gel filtration column (GE Healthcare) and adjusted to a final protein concentration of 8 mg/ml. The purity of the protein was determined to be 498% as analyzed by SDS-PAGE and Coomassie blue staining (data not shown).
Crystal grow, data collection and structure determination Crystals of CRF07 gp41 were grown using the sitting-drop vapor diffusion method at 4 1C by mixing equal volumes (1 μl each) of the protein solution (at 8 mg/ml in 20 mM Tris pH 8.0, 500 mM NaCl) and the reservoir solution (8% PEG6000, 0.1 M Tris, pH 8.5, 40% MPD). Before data collection, crystals were flash frozen at 100 K with paraffin oil as cryoprotectant. Data was collected at 100 K using a wavelength of 0.9793 Å in Shanghai Synchrotron Radiation Facility, and processed in HKL2000 package (Otwinowski and Minor, 1997) . Data collection and processing results are summarized in Table 1. For the structure determination, the structure of clade B gp41 (PDB code 1AIK) was used for molecular replacement. The Phenix refinement program (phenix.refine) was used for refinement (Adams et al., 2010) . Simulated annealing, positional refinement and B-factor refinement were used in multiple rounds to improve the quality of the structure. Ordered water molecules were added to the structure in the last round of refinement. Refinement statistics are summarized in Table 1 .
Circular dichroism spectroscopy
The protocol was adapted from a previously published method (Pozdnyakova and Regan, 2005) . Briefly, CD measurements were performed using a Biologic M450 (BioLogic science In., France) Spectropolarimeter equipped with a thermoelectric temperature controller. Spectra of each protein were measured at 5 1C in 1 nm steps from 190 to 260 nm in PBS buffer. For thermal denaturation experiments, the ellipticity was measured at 222 nm with 1 1C steps from 5 1C to 95 1C at a rate of 90 1C/h. Thermal melting (Tm) points were calculated with a Boltzmann sigmoidal fit using OriginLab.
Cell-cell fusion assay
COS-1 cells in six-well plates were transfected with pSRHSgp160 (1.5 mg/well). Cells transfected with pcDNA3.1 (1.5 mg/well) were used as negative control. After culturing for 24 h, transfected COS-1 cells were removed using trypsin, washed, and resuspended in fresh medium. To initiate cell-cell fusion, equal numbers of TZM-bl cells were overlaid on confluent COS-1 in 12-well plates and coincubated at 37 1C overnight. After coincubation, the cells were washed and lysed in reporter lysis buffer (100 ml/well), and assayed for luciferase activity according to manufacturer's instructions (Promega, USA)
Pseudo-virus generation and fusion activity test
HIV-1 pseudo-viruses were produced in 293T cells by cotransfection of pNL4-3-ENV-Luc+ and HIV-1 envelope expression vectors pSRHS-gp160 using the Lipofectamine2000 Transfection System (Invitrogen, USA). HIV-1 pseudo-virus was harvested in culture supernatants at 48 h post-transfection. Supernatants were clarified by centrifuging at 1500g for 10 min. Virus titer was determined by ELISA (Biomerieux, France) to quantify viral p24. The fusion activity of the pseudo-virus was measured the luciferase activity through adding the virus to TZM-bl cell line, the procedure just like the cell-cell fusion test. 24 h post-infection, the TZM-bl cells were washed and lysed in reporter lysis buffer (100 ml/well), and assayed for luciferase activity according to manufacturer's instructions (Promega, USA).
Western blotting
To analysis Env protein expression, transfected COS-1 cells were lysed with NP-40 lysis buffer, containing 1% PMSF, for 30 min on ice. After centrifugation (10,000g, 10 min, 4 1C), the supernatant was separated by SDS-PAGE. Proteins were transferred to PVDF membrane (GE Healthcare) for 1 h at 100 V, 4 1C in a Mini Transblot apparatus from BioRad. The membrane was blocked in 5% non-fat milk (in PBS buffer) for 45 min at RT (room temperature) to quench unspecific binding. Primary antibody was usually diluted 1:5000 in blocking buffer and incubated 90 min at RT or overnight at 4 1C. Membranes were washed 4 times for 5 min each. The appropriate horse radish peroxidase-conjugated secondary antibody was diluted 1:8000 in blocking buffer and applied to the membrane for 45 min at RT. Protein bands were detected using enhanced chemiluminescence reagents (Millipore) and visualized on Kodak Scientific Imaging Film.
Accession number
Atomic coordinates and structure factors have been deposited in the RCSB Protein Data Bank under ID codes 3WFV.
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